| Bioactivity | Pyruvate Carboxylase-IN-3 (Compd 36) is a potent Pyruvate Carboxylase inhibitor. Pyruvate Carboxylase-IN-3 inhibits hepatocellular carcinoma cells activity with an IC50 of 4.3 μM[1]. |
| Formula | C18H18D3FO4 |
| Molar Mass | 323.37 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Shi H, et al. Design, synthesis and structure-activity relationship studies on erianin analogues as pyruvate carboxylase inhibitors in hepatocellular carcinoma cells. Org Biomol Chem. 2023 Aug 30;21(34):7005-7017. |
Pyruvate Carboxylase-IN-3
CAS: F: C18H18D3FO4 W: 323.37
Pyruvate Carboxylase-IN-3 (Compd 36) is a potent Pyruvate Carboxylase inhibitor. Pyruvate Carboxylase-IN-3 inhibits hepa
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.